VXRT Vaxart Operating Profitability

Public company logo of Vaxart Corp (VXRT)

The EBIT margin demonstrates the resilience of Vaxart, Inc. (VXRT), which relies on domestic government cycles regardless of the global crisis. The 0.00 indicator expresses the state of the operational efficiency metric. Vaxart, Inc. (VXRT) strives for pricing power by creating unique tablet vaccines. However, the company is engaged in a risky battle against traditional injections, proving the effectiveness of its method in clinical trials.

VXRT - Vaxart, Inc. Operating Profit Ratio over the range 07/04/2022 - 07/19/2025

VXRT (Vaxart Corp): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
General company analysis:Vaxart Inc., VXRT
Finished products of Vaxart Inc.

Vaxart, Inc. focuses on developing innovative tablet vaccines, whose financial stability depends critically on external government grants and the success of clinical trials. The operating margin time series, which reached a value of 0.00, reflects the share of profit from core operations before interest and taxes, allowing investors to assess cost management efficiency and the actual strength of the asset's market price.